DURECT Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$28.16 | $32.87 | 8.31% | 6 | $157.48B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$14.06 | $11.59 | 13.80% | 9 | $15.83B |
| VTRS | Viatris Inc | Hold |
8
|
$11.82 | $11.73 | 5.75% | 5 | $13.74B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.42 | $41.00 | 31.49% | 0 | $1.69B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.50 | CHF76.55 | 29.05% | 0 | CHF1.16B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.02 | $37.75 | 8.05% | 1 | $1.23B |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$5.16 | $19.50 | 258.53% | 1 | $253.06M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | $8.50 | -100.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | Buy |
6
|
$1.03 | $4.63 | 398.06% | 0 | $21.53M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | $1.50 | -100.00% | 0 | $0.35M |